Rich Pharmaceuticals, Inc. Contracts & Agreements

89 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Assignment Agreement between Richard L. Chang Holding's, LLC and Rich Pharmaceuticals, Inc.
Assignment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2019
Asset Licensing Agreement between Rich Pharmaceuticals Inc. and Geopulse Corporation, Inc.
License Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2019
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and Richard L. Chang Holdings, LLC (June 19, 2019)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2019
Rich Pharmaceuticals, Inc. 2019 Stock Option/Stock Issuance Plan
Equity Distribution Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2019
Plan of Conversion of Rich Pharmaceuticals, Inc. from Nevada to Wyoming
Plan of Reorganization Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
WY
2018
Support and Collaboration Agreement between Rich Pharmaceuticals, Inc. and Mega Bridge, Inc. (Hypgen)
Collaboration Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Rich Pharmaceuticals, Inc. 2017 Stock Option and Stock Issuance Plan
Bonus & Incentive Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2017
Rich Pharmaceuticals, Inc. 2017 Stock Option and Stock Issuance Plan
Equity Distribution Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2017
Collaboration Agreement between Rich Pharmaceuticals, Inc. and I Tech Health Corp. for CannCodex Business
Collaboration Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Equity Financing Agreement between Rich Pharmaceuticals, Inc. and GHS Investments LLC dated February 22, 2017
Equity Distribution Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Affidavit of Confession of Judgment between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc.
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Affidavit of Confession of Judgment between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc.
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Amendment No. 3 to Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan
Bonus & Incentive Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Employment Agreement between Rich Pharmaceuticals, Inc. and Richard Salvador (Chief Clinical Officer)
Employment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2015
Security Agreement between Rich Pharmaceuticals, Inc. and Typenex Co-Investment, LLC dated May 27, 2015
Security Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Amendment No. 2 to Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan
Bonus & Incentive Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Assignment Agreement for Patent Assets between Rich Pharmaceuticals, Inc., Richard L. Chang Holding’s, LLC, and Imagic LLC (October 6, 2014)
Assignment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2014
Amendment to Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan (October 6, 2014)
Equity Distribution Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Investment Agreement between Rich Pharmaceuticals, Inc. and Macallan Partners, LLC (August 12, 2014)
Investment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Waiver to Memorandum of Understanding and Asset Assignment Agreement between Rich Pharmaceuticals, Inc., Imagic, LLC, and Richard L. Chang Holding's, LLC
Waiver Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Employment Agreement between Rich Pharmaceuticals, Inc. and Ben Chang (CEO, CFO, President)
Employment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2013
Rich Pharmaceuticals, Inc. 2013 Stock Option and Stock Issuance Plan
Equity Distribution Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2013
Agreement of Conveyance, Transfer and Assignment of Assets and Assumption of Obligations between Nepia, Inc. and Li Deng Ke & Xiong Chao Jun
Assignment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2013
Memorandum of Understanding and Asset Assignment Agreement among Nepia, Inc., Rich Pharmaceuticals, Inc., and Richard L. Chang Holding's, LLC
Assignment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2013
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and SD Law Group APC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (March 15, 2018)
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated March 15, 2018
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (January 10, 2018)
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (November 3, 2017)
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (November 3, 2017)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (April 18, 2017)
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated April 18, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 22, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Registration Rights Agreement between Rich Pharmaceuticals, Inc. and GHS Investments LLC (February 22, 2017)
Registration Rights Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2017
Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 21, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (February 21, 2017)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Debt Purchase Agreement between LG Capital Funding, LLC and GHS Investments, LLC regarding Rich Pharmaceuticals, Inc. Convertible Notes
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 20, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note between Rich Pharmaceuticals, Inc. and GHS Investments, LLC dated February 21, 2017
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NV
2017
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (January 5, 2017)
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Promissory Note and Convertible Debt Agreement between Rich Pharmaceuticals, Inc. and GHS Investments, LLC (January 5, 2017)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2017
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and LG Capital Funding, LLC (October 20, 2016)
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due October 20, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and LG Capital Funding, LLC dated June 23, 2016
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 23, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 23, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc. dated June 23, 2016
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and LG Capital Funding, LLC dated June 8, 2016
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 8, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due June 8, 2017 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc. dated June 8, 2016
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Secured Promissory Note between Company and Computerlaw Group LLP dated May 31, 2016
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2016
Amended and Restated Investment Agreement between Rich Pharmaceuticals, Inc. and LG Capital Funding, LLC (June 10, 2015)
Investment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and Typenex Co-Investment, LLC dated May 27, 2015
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Secured Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Typenex Co-Investment, LLC dated May 27, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Secured Investor Note #1 between Typenex Co-Investment, LLC and Rich Pharmaceuticals, Inc. dated May 27, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
UT
2015
Investment Agreement between Rich Pharmaceuticals, Inc. and LG Capital Funding, LLC (May 19, 2015)
Investment Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and LG Capital Funding, LLC dated May 5, 2015
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due May 5, 2016 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due May 5, 2016 (with LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Rich Pharmaceuticals, Inc. dated May 5, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Vis Vires Group, Inc. dated May 6, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and Adar Bays, LLC dated March 26, 2015
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due March 26, 2016 (Adar Bays, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note with Adar Bays, LLC (Due March 26, 2016)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Collateralized Secured Promissory Note between Adar Bays, LLC and Rich Pharmaceuticals, Inc. dated March 26, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2015
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and Auctus Private Equity Fund, LLC dated March 9, 2015
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Auctus Private Equity Fund, LLC dated March 9, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated February 5, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated January 9, 2015
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2015
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated November 25, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated October 6, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
12% Convertible Note Agreement between Rich Pharmaceuticals, Inc. and JSJ Investments Inc. dated November 6, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
TX
2014
Master Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Typenex Co-Investment, LLC (September 18, 2014)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and Auctus Private Equity Fund, LLC (September 23, 2014)
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Auctus Private Equity Fund, LLC dated September 23, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
MA
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated April 8, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and KBM Worldwide, Inc. dated May 21, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Registration Rights Agreement between Rich Pharmaceuticals, Inc. and Macallan Partners dated August 12, 2014
Registration Rights Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Rich Pharmaceuticals, Inc. $350,000 Convertible Note Agreement with JMJ Financial
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
FL
2014
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and Toledo Advisors, LLC dated August 14, 2014
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due August 14, 2015 (Toledo Advisors, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due August 14, 2015 (Toledo Advisors, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Securities Purchase Agreement between Rich Pharmaceuticals, Inc. and LG Capital Funding, LLC dated August 14, 2014
Purchase Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due August 14, 2015 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Rich Pharmaceuticals, Inc. 8% Convertible Redeemable Note Due August 14, 2015 (LG Capital Funding, LLC)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
2014
Rich Pharmaceuticals, Inc. Convertible Note Agreement with Vista Capital Investments, LLC (August 14, 2014)
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
CA
2014
Convertible Promissory Note between Rich Pharmaceuticals, Inc. and Asher Enterprises, Inc. dated March 11, 2014
Note Agreements
Rich Pharmaceuticals, Inc.
Biotechnology
NY
2014